P. Boxer

发表

The voltage-sensitive Ca2+ channel (VSCC) antagonists ω-Aga-IVA and ω-CTX-MVIIC inhibit spontaneous epileptiform dischares in the rat cortical wedge

S. Wurster, L. Robichaud, P. Boxer, 1994, Brain Research.

N-sulfonyl derivatives of 6,7-dichloro 3,4-dihydro-3-oxo-quinoxalinecarboxylate as glycine-site NMDA and AMPA antagonists

E. Nielsen, C. Taylor, L. Robichaud, 1993 .

Hyperpolarizing membrane responses induced in lumbar motoneurons by stimulation of the nucleus reticularis pontis oralis during active sleep

Michael H. Chase, Simon J. Fung, Francisco R. Morales, 1982, Brain Research.

Noninvasive assessment of the relative roles of cerebral antioxidant enzymes by quantitation of pentose phosphate pathway activity

B. Ross, P. Boxer, O. Ben-Yoseph, 1996, Neurochemical Research.

Oxidative stress in the central nervous system: monitoring the metabolic response using the pentose phosphate pathway.

B. Ross, P. Boxer, O. Ben-Yoseph, 1994, Developmental neuroscience.

Assessment of the Role of the Glutathione and Pentose Phosphate Pathways in the Protection of Primary Cerebrocortical Cultures from Oxidative Stress

B. Ross, P. Boxer, O. Ben-Yoseph, 1996, Journal of neurochemistry.

Functional Differences Between Monocyte Chemotactic Protein-1 Receptor A and Monocyte Chemotactic Protein-1 Receptor B Expressed in a Jurkat T Cell

S. Sanders, G. Larosa, S. Hunt, 2000, The Journal of Immunology.

Psychiatric diagnoses of Cuban refugees in the United States: findings of medical review boards.

J. Garvey, P. Boxer, 1985, The American journal of psychiatry.

The neuroprotective effect of the novel AMPA receptor antagonist PD152247 (PNQX) in temporary focal ischemia in the rat.

C. Iadecola, D. Welty, C. Bigge, 1999, Stroke.

Contribution of the ICE Family to Neurodegeneration

J. Vasilakos, B. Shivers, G. P. Schielke, 1998, Annals of the New York Academy of Sciences.

The voltage-sensitive Ca2+ channel (VSCC) antagonists omega-Aga-IVA and omega-CTX-MVIIC inhibit spontaneous epileptiform discharges in the rat cortical wedge.

S. Wurster, L. Robichaud, P. Boxer, 1994, Brain research.

Substituted 2-benzothiazolamines as sodium flux inhibitors: quantitative structure-activity relationships and anticonvulsant activity.

D. Ortwine, R. Schwarz, P. Boxer, 1994, Journal of pharmaceutical sciences.

Synthesis and SAR of tolylamine 5-HT6 antagonists.

L. W. Cooke, Paul D. Johnson, L. Gold, 2009, Bioorganic & medicinal chemistry letters.

Subtype-selective N-methyl-D-aspartate receptor antagonists: synthesis and biological evaluation of 1-(heteroarylalkynyl)-4-benzylpiperidines.

S. Espitia, L. Wise, E. R. Whittemore, 2001, Journal of medicinal chemistry.

A specific inhibitor of calcium/calmodulin-dependent protein kinase-II provides neuroprotection against NMDA- and hypoxia/hypoglycemia-induced cell death

K. Wang, F. Marcoux, P. Boxer, 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

Chapter 2. Neuronal Cell Death and Strategies for Neuroprotection

C. Bigge, P. Boxer, 1994 .

Polyamine modulation of excitatory amino acid responses in the rat cortical wedge

L. Robichaud, P. Boxer, 1993, Neuropharmacology.

NS 257 (1,2,3,6,7,8-hexahydro-3(hydroxyimino)-N,N,7-trimethyl-2-oxobenzo[2,1-b:3,4-c']dipyrrole-5-sulfonamide) is a potent, systemically active ampa receptor antagonist

E. Nielsen, F. Marcoux, J. Drejer, 1994 .

A new Legionella species, Legionella feeleii species nova, causes Pontiac fever in an automobile plant.

L A Herwaldt, C. W. Moss, A. Steigerwalt, 1984, Annals of internal medicine.

Production of collagenase by mouse peritoneal macrophages in vitro. Characterization of sites of cleavage of tropocollagen.

S. Leibovich, P. Boxer, 1976, Biochimica et biophysica acta.

Mechanisms of neuronal cell injury/death and targets for drug intervention

C. Bigge, P. Boxer, 1997 .

4-Hydroxy-1-[2-(4-hydroxyphenoxy)ethyl]-4-(4-methylbenzyl)piperidine: a novel, potent, and selective NR1/2B NMDA receptor antagonist.

J. Hawkinson, S. Espitia, L. Wise, 1999, Journal of medicinal chemistry.

Synthesis of 1,4,7,8,9,10-hexahydro-9-methyl-6-nitropyrido[3,4-f]- quinoxaline-2,3-dione and related quinoxalinediones: characterization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (and N-methyl-D-aspartate) receptor and anticonvulsant activity.

D. Ortwine, C. Bigge, P. Boxer, 1995, Journal of medicinal chemistry.

Design and synthesis of novel quinoxaline-2,3-dione AMPA/GlyN receptor antagonists: amino acid derivatives.

A. Blackburn, T. Heimbach, D. Ortwine, 1999, Journal of medicinal chemistry.

Nutrient plasma levels achieved during treatment that reduces noise-induced hearing loss.

C. L. Le Prell, D. Dolan, P. Boxer, 2011, Translational research : the journal of laboratory and clinical medicine.

Inhibitors of V‐Type ATPases, Bafilomycin A1 and Concanamycin A, Protect Against β‐Amyloid‐Mediated Effects on 3‐(4,5‐Dimethylthiazol‐2‐yl)‐2,5‐Diphenyltetrazolium Bromide (MTT) Reduction

M. Emmerling, R. Schwarz, P. Boxer, 1999, Journal of neurochemistry.

Effect of stimulation of the nucleus reticularis gigantocellularis on the membrane potential of cat lumbar motoneurons during sleep and wakefulness

Michael H. Chase, Simon J. Fung, Francisco R. Morales, 1986, Brain Research.

Behavioral state-specific inhibitory postsynaptic potentials impinge on cat lumbar motoneurons during active sleep

Michael H. Chase, Francisco R. Morales, F. Morales, 1987, Experimental Neurology.

Emerging Therapeutic Advances for the Development of Second Generation Matrix Metalloproteinase Inhibitors

A. D. White, D. Schrier, T. Bocan, 1997, Current Pharmaceutical Design.

Discovery of subtype-selective NMDA receptor ligands: 4-benzyl-1-piperidinylalkynylpyrroles, pyrazoles and imidazoles as NR1A/2B antagonists.

L. Wise, P. Boxer, L. Meltzer, 1999, Bioorganic & medicinal chemistry letters.

Aging of motoneurons and synaptic processes in the cat

F. Morales, P. Boxer, M. Chase, 1985, Experimental Neurology.

Expressed in a Jurkat T Cell Monocyte Chemotactic Protein-1 Receptor B Chemotactic Protein-1 Receptor A and Functional Differences Between Monocyte

S. Sanders, S. Crean, G. Larosa, 2000 .

A computerized system for the detection and analysis of spontaneously occurring synaptic potentials

Michael H. Chase, J. Jervey, Francisco R. Morales, 1985, Journal of Neuroscience Methods.

Comparison of phenytoin with noncompetitive N-methyl-D-aspartate antagonists in a model of focal brain ischemia in rat.

F. Marcoux, L. Rodolosi, P. Boxer, 1990, Stroke.

Subtype-selective N-methyl-D-aspartate receptor antagonists: synthesis and biological evaluation of 1-(arylalkynyl)-4-benzylpiperidines.

J. Hawkinson, L. Wise, E. R. Whittemore, 1999, Journal of medicinal chemistry.

Alterations of group IA-motoneuron monosynaptic EPSPs in aged cats

F. Morales, P. Boxer, M. Chase, 1988, Experimental Neurology.

The design and synthesis of human branched-chain amino acid aminotransferase inhibitors for treatment of neurodegenerative diseases.

R. T. Carroll, Xiaohong Liu, J. Rubin, 2006, Bioorganic & medicinal chemistry letters.